XML 64 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-based Compensation
9 Months Ended
Mar. 31, 2014
Share-based Compensation [Abstract]  
Share-based Compensation
Share-based Compensation
Share-based compensation expense recognized in the condensed consolidated financial statements by line item caption is as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
March 31,
2014
 
March 31,
2013
 
March 31,
2014
 
March 31,
2013
Cost of product revenue
$
268

 
$
118

 
$
568

 
$
413

Cost of service revenue
420

 
61

 
623

 
304

Research and development
1,419

 
268

 
2,559

 
988

Sales and marketing
1,765

 
756

 
3,614

 
2,051

General and administrative
970

 
638

 
2,510

 
1,869

Total share-based compensation expense
$
4,842

 
$
1,841

 
$
9,874

 
$
5,625


During the three and nine months ended March 31, 2014 and 2013, the Company did not capitalize any stock-based compensation expense in inventory, as the amounts were immaterial. The income tax benefit for share-based compensation expense was immaterial in the three and nine months ended March 31, 2014 and 2013.  
The weighted-average grant-date per share fair value of options granted during the three months ended March 31, 2014 and 2013 was $2.71 and $1.72, respectively. The weighted-average estimated per share fair value of shares purchased under the Company’s 1999 Employee Stock Purchase Plan (“ESPP”) during the three months ended March 31, 2014 and 2013 was $1.62 and $0.86, respectively.
The weighted-average grant-date per share fair value of options granted during the nine months ended March 31, 2014 and 2013 was $2.39 and $2.71, respectively. The weighted-average estimated per share fair value of shares purchased under the ESPP during the nine months ended March 31, 2014 and 2013 was $1.44 and $0.88, respectively.
The following table summarizes stock option activity under all plans for the nine months ended March 31, 2014:
 
 
Number of
Shares
(000’s)
 
Weighted-
Average
Exercise Price
Per Share
 
Weighted-
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic Value
(000’s)
Options outstanding at June 30, 2013
9,145

 
$
3.66

 
 
 
 
Granted
6,097

 
$
5.22

 
 
 
 
Exercised
(1,676
)
 
$
3.60

 
 
 
$
1,036

Cancelled
(1,323
)
 
$
4.92

 
 
 
 
Options outstanding at March 31, 2014
12,243

 
$
4.31

 
5.50
 
$
18,367

Exercisable at March 31, 2014
3,926

 
$
3.78

 
3.80
 
$
8,040

Vested and expected to vest at March 31, 2014
11,247

 
$
4.28

 
5.42
 
$
17,301


Included in the options granted above are 4.2 million options, assumed in connection with the acquisition of Enterasys on October 31, 2013, with an exercise price of $5.30.
Stock Awards
Stock awards may be granted under the 2013 Plan on terms approved by the Board of Directors. Stock awards generally provide for the issuance of restricted stock which vests over a fixed period.

The following table summarizes stock award activity for the nine months ended March 31, 2014:
 
 
Number of
Shares
(000’s)
 
Weighted-
Average Grant-
Date Fair Value
 
Aggregate Fair Market Value ($000's)
Non-vested stock outstanding at June 30, 2013
2,686

 
$
3.09

 
 
Granted
5,037

 
$
5.56

 
 
Vested
852

 
$
3.51

 
$
4,982

Cancelled
515

 
$
2.62

 
 
Non-vested stock outstanding at March 31, 2014
9,090

 
$
4.47

 
 


Included in the restricted stock units granted above are 2.7 million restricted stock units assumed in connection with the acquisition of Enterasys on October 31, 2013, with an acquisition-date fair value of $5.30.
Excluding the options assumed as part of the Enterasys acquisition, the fair value of each option award and share purchase option under the Company's ESPP is estimated on the date of grant using the Black-Scholes-Merton option valuation model with the weighted average assumptions noted in the following table.
The Company uses the Monte-Carlo simulation model to determine the fair value and the derived service period of performance-based option awards, with market conditions, on the date of the grant. The expected term of options granted is derived from historical data on employee exercise and post-vesting employment termination behavior. The expected term of ESPP represents the contractual life of the ESPP purchase period. The risk-free rate based upon the estimated life of the option and ESPP is based on the U.S. Treasury yield curve in effect at the time of grant. Expected volatility is based on both the implied volatilities from traded options on the Company’s stock and historical volatility on the Company’s stock.  
 
Stock Option Plan
 
Employee Stock Purchase Plan
 
Stock Option Plan
 
Employee Stock Purchase Plan
 
Three Months Ended
 
Three Months Ended
 
Nine Months Ended
 
Nine Months Ended
 
March 31,
2014
 
March 31,
2013
 
March 31,
2014
 
March 31,
2013
 
March 31,
2014
 
March 31,
2013
 
March 31,
2014
 
March 31,
2013
Expected life
5 years

 
4 years

 
0.25 years

 
0.25 years

 
4 years

 
5 years

 
0.25 years

 
0.25 years

Risk-free interest rate
1.41
%
 
0.72
%
 
0.09
%
 
0.10
%
 
1.23
%
 
0.71
%
 
0.10
%
 
0.07
%
Volatility
57
%
 
62
%
 
57
%
 
42
%
 
56
%
 
60
%
 
51
%
 
53
%
Dividend yield
%
 
%
 
%
 
%
 
%
 
%
 
%
 
%

The Company is required to estimate the expected forfeiture rate and only recognize expense on a straight-line method for those shares expected to vest.